HYPR
Hyperfine, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.82
−1.54%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.8x
Market Cap
$87.39M
MomentumView details →
1D Return
−1.54%
YTD Return
−15.98%
RSI (14)
31.6
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.8x
Market Cap
$87.39M
RSI (14)
31.6
MomentumView details →
1D Return
−1.54%
YTD Return
−15.98%
SummaryUpdated Jun 1, 2026
Hyperfine, Inc. (NASDAQ:HYPR) is a medical device company founded in 2014 and based in Guilford, Connecticut. The company went public in January 2021 through a SPAC merger. Hyperfine develops and commercializes portable magnetic resonance imaging (MRI) technology, with its flagship product being the Swoop Portable MR imaging system. The company represents a pioneering effort to make MRI technology more accessible by creating a portable, point-of-care solution that can be deployed in various healthcare settings beyond traditional hospital radiology departments.
Similar companies
Latest newsMore news →
Hyperfine announced the publication of peer-reviewed NEURO PMR results and reported over 3,000 office brain MRI scans, supporting the growing use of the Swoop system in neurology practices during the first year of its neurology office launch.9d agoHyperfine announced FDA clearance of its next Optive AI software, enhancing image quality, clinical utility, ease of use, and isotropic imaging capability of the Swoop system across care settings.15d agoHyperfine, Inc. reported its second quarter 2026 financial results on August 6, 2026, highlighting growth in placements and revenue, gross margin expansion, and disciplined operating expenses.29d ago